EUVIMEDEUVIMED entdecken
Vergleichsstudie

Impact of Preoperative Semaglutide Discontinuation Timing on Postoperative Outcomes in Aesthetic Abdominoplasty: A Retrospective Comparative Study

Agostino Bruno, Alessio Calicchia, Marco Schirosi

Aesthetic Plastic Surgery · 2026-08 · 50 (15) · 6564-6570

DOI: 10.1007/s00266-026-05978-x ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Aesthetic Plastic Surgery, online erschienen am 12.06.2026. Verfasst von Agostino Bruno und 2 weiteren Autor:innen. Beteiligte Einrichtung: Santa Maria di Leuca Clinic, Via Tiberina 173, 00188, Rome, Italy. dott.agostinobruno@gmail.com. Hauptthemen laut MEDLINE: Glucagon-Like Peptides, Postoperative Complications, Abdominoplasty, Lipoabdominoplasty. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 25 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The widespread adoption of GLP-1 receptor agonists such as semaglutide for weight loss has led to an increasing number of non-diabetic patients seeking body contouring procedures after pharmacologic weight reduction. However, concerns have emerged regarding postoperative complications potentially linked to GLP-1 therapy, particularly when continued up to the time of surgery.

Objectives

This retrospective cohort study aimed to evaluate the impact of preoperative semaglutide discontinuation timing on short-term postoperative outcomes in aesthetic lipoabdominoplasty.

Methods

Eighty patients who underwent primary lipoabdominoplasty were divided into four groups: continued semaglutide until surgery (Group A), 2-week discontinuation (Group B), 4-week discontinuation (Group C), and semaglutide-naïve controls (Group D). All patients were matched for age, BMI, and surgical technique. Postoperative complications within 30 days were assessed.

Results

Group A exhibited the highest complication rate (45%), including wound dehiscence, infection, and seroma formation. Group B showed moderate improvement (30% complication rate), while Group C demonstrated a significant reduction in adverse outcomes (10%), comparable to the control group (10%). Gastrointestinal intolerance and prolonged drain duration were also more frequent in patients with ongoing semaglutide use. No reoperations or readmissions occurred.

Conclusions

Continuation of semaglutide until surgery significantly increases postoperative complication risk in lipoabdominoplasty. A 4-week preoperative discontinuation period effectively normalizes outcomes, supporting its use as a safety measure in aesthetic surgery candidates. These findings emphasize the need for standardized perioperative management protocols for patients on GLP-1 therapy and underscore the importance of interdisciplinary coordination and nutritional assessment. Level of Evidence III This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266 .

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Glucagon-Like PeptidesPostoperative ComplicationsAbdominoplastyLipoabdominoplastyHumansSemaglutideRetrospective StudiesFemaleMiddle AgedAdultMaleTreatment OutcomePreoperative CareCohort StudiesRisk AssessmentTime FactorsFollow-Up StudiesEstheticsDrug Administration ScheduleTreatment Interruption

Stichwörter der Autor:innen

Aesthetic surgeryGLP-1 receptor agonistLipoabdominoplastyPreoperative managementSemaglutideWound complications

Substanzen

SemaglutideGlucagon-Like Peptides

Autor:innen und Institutionen

  • Santa Maria di Leuca Clinic, Via Tiberina 173, 00188, Rome, Italy. dott.agostinobruno@gmail.com.
  • Plastic Surgery, Department of Surgical Sciences, Tor Vergata University of Rome, Rome, Italy.
  • Santa Maria di Leuca Clinic, Via Tiberina 173, 00188, Rome, Italy.

Zitieren

APA

Bruno, A., Calicchia, A., & Schirosi, M. (2026). Impact of Preoperative Semaglutide Discontinuation Timing on Postoperative Outcomes in Aesthetic Abdominoplasty: A Retrospective Comparative Study. Aesthetic Plastic Surgery, 50(15), 6564-6570. https://doi.org/10.1007/s00266-026-05978-x

Vancouver

Bruno A, Calicchia A, Schirosi M. Impact of Preoperative Semaglutide Discontinuation Timing on Postoperative Outcomes in Aesthetic Abdominoplasty: A Retrospective Comparative Study. Aesthetic Plastic Surgery. 2026;50(15):6564-6570. doi:10.1007/s00266-026-05978-x

BibTeX
@article{Bruno2026,
  author = {Bruno, Agostino and Calicchia, Alessio and Schirosi, Marco},
  title = {Impact of Preoperative Semaglutide Discontinuation Timing on Postoperative Outcomes in Aesthetic Abdominoplasty: A Retrospective Comparative Study},
  journal = {Aesthetic Plastic Surgery},
  year = {2026},
  volume = {50},
  number = {15},
  pages = {6564--6570},
  doi = {10.1007/s00266-026-05978-x}
}
Kostenlos starten →